CEOs of NVIDIA and Lilly Share ‘Blueprint for What Is Possible’ in AI and Drug Discovery

NVIDIA and Lilly are putting together “a blueprint for what is possible in the future of drug discovery,” NVIDIA founder and CEO Jensen Huang told attendees at a fireside chat Monday with Dave Ricks, chair and CEO of Lilly. The conversation — which took place during the annual J.P. Morgan Healthcare Conference in San Francisco Read Article